Table 4. The association between five-lncRNA signature and OS of GC patients in training group.
Number (High Risk score/Low Risk score) | HR (95% CI) | P value | |
---|---|---|---|
Total | 204/204 | 2.09 (1.80, 2.44) | 0.000001 |
Gender | |||
Male | 129/134 | 2.29 (1.53, 3.44) | 0.00002 |
Female | 75/70 | 1.97 (1.11, 3.47) | 0.01 |
Histologic grade | |||
G2 | 47/97 | 2.41 (1.34, 4.33) | 0.0006 |
G3 | 146/97 | 1.68 (1.13, 2.50) | 0.02 |
Race | |||
Asian | 44/41 | 5.47 (1.87, 16.02) | 0.001 |
Black or african american | 4/8 | 1.78 (0.32, 9.80) | 0.6 |
White | 138/120 | 2.16 (1.44, 3.24) | 0.0003 |
Age | |||
Old (≥50 years old) | 186/191 | 2.04 (1.46, 2.86) | 0.00001 |
Young(<50 years old) | 18/13 | 5.96 (1.26, 28.17) | 0.008 |
TNM stage | |||
Stage I | 14/41 | 2.09 (0.63, 6.93) | 0.3 |
Stage II | 62/58 | 2.78 (1.34, 5.78) | 0.008 |
Stage III | 88/79 | 1.68 (1.06, 2.66) | 0.02 |
Stage IV | 25/16 | 2.04 (0.87, 4.78) | 0.01 |
Notes.
Abbreviations
- HR
- Hazard ratio
- 95%CI
- 95% confidence interval